Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Saito, Masataka ^a   Stahley, Sara N ^a   Caughman, Christopher Y ^a   Mao, Xuming ^b   Tucker, Dana K ^a   Payne, Aimee S ^b   Amagai, Masayuki ^c   Kowalczyk, Andrew P ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DESMOGLEIN 3; DISPASE; GENISTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR; KERATIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY;

ARTICLE; BLISTER; CELL ADHESION; CELL SIZE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CROSS LINKING; DESMOSOME; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; PEMPHIGUS VULGARIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BLISTER; CELL ADHESION; CLUSTER ANALYSIS; DESMOGLEIN 3; DESMOSOMES; ENDOCYTOSIS; GENISTEIN; HUMANS; IMIDAZOLES; IMMUNOGLOBULIN G; KERATINOCYTES; MICE; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEMPHIGUS; PROTEIN STRUCTURE, TERTIARY; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 84870659354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050696     Document Type: Article

References (56)

1. Delva E, Tucker DK, Kowalczyk AP, (2009) The desmosome. Cold Spring Harb Perspect Biol 1: a002543.
2. Getsios S, Huen AC, Green KJ, (2004) Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 5: 271-281.
3. Yin T, Green KJ, (2004) Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 15: 665-677.
4. Amagai M, Stanley JR, (2012) Desmoglein as a target in skin disease and beyond. J Invest Dermatol 132: 776-784.
5. Brooke MA, Nitoiu D, Kelsell DP, (2012) Cell-cell connectivity: desmosomes and disease. J Pathol 226: 158-171.
6. Green KJ, Getsios S, Troyanovsky S, Godsel LM, (2010) Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2: a000125.
7. Amagai M, (2010) Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci 86: 524-537.
8. Amagai M, Klaus-Kovtun V, Stanley JR, (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67: 869-877.
9. Anhalt GJ, Diaz LA, (2004) Pemphigus vulgaris-a model for cutaneous autoimmunity. J Am Acad Dermatol 51: S20-21.
10. Payne AS, Hanakawa Y, Amagai M, Stanley JR, (2004) Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol 16: 536-543.
11. Waschke J, (2008) The desmosome and pemphigus. Histochem Cell Biol 130: 21-54.
12. Getsios S, Waschke J, Borradori L, Hertl M, Muller EJ, (2010) From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol 130: 1764-1768.
13. Sharma P, Mao X, Payne AS, (2007) Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 48: 1-14.
14. Heupel WM, Zillikens D, Drenckhahn D, Waschke J, (2008) Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 181: 1825-1834.
15. Shapiro L, Weis WI, (2009) Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 1: a003053.
16. Mascaro JM Jr, Espana A, Liu Z, Ding X, Swartz SJ, et al. (1997) Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol 85: 90-96.
17. Payne AS, Ishii K, Kacir S, Lin C, Li H, et al. (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115: 888-899.
18. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, et al. (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170: 2170-2178.
19. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, et al. (2005) Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 280: 23778-23784.
20. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, et al. (2006) p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A 103: 12855-12860.
21. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA, (2007) Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 282: 13804-13812.
22. Seishima M, Iwasaki-Bessho Y, Itoh Y, Nozawa Y, Amagai M, et al. (1999) Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch Dermatol Res 291: 606-613.
23. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, et al. (2006) Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 175: 721-727.
24. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, et al. (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25: 3298-3309.
25. Sanchez-Carpintero I, Espana A, Pelacho B, Lopez Moratalla N, Rubenstein DS, et al. (2004) In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 151: 565-570.
26. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, et al. (2008) Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem 283: 18303-18313.
27. Spindler V, Waschke J, (2011) Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis. Ann Anat 193: 177-180.
28. Jolly PS, Berkowitz P, Bektas M, Lee HE, Chua M, et al. (2010) p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 285: 8936-8941.
29. Mao X, Sano Y, Park JM, Payne AS, (2011) p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 286: 1283-1291.
30. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, et al. (2006) Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 281: 7623-7634.
31. Jennings JM, Tucker DK, Kottke MD, Saito M, Delva E, et al. (2011) Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol 131: 706-718.
32. Mao X, Choi EJ, Payne AS, (2009) Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol 129: 908-918.
33. Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, et al. (2007) Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 282: 17866-17876.
34. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, et al. (2005) p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell 16: 5141-5151.
35. Chiasson CM, Wittich KB, Vincent PA, Faundez V, Kowalczyk AP, (2009) p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. Mol Biol Cell 20: 1970-1980.
36. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, et al. (2001) Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167: 5439-5448.
37. Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, et al. (2009) Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 129: 2156-2166.
38. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, et al. (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103: 461-468.
39. Stanley JR, Amagai M, (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355: 1800-1810.
40. Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, et al. (2001) A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 153: 823-834.
41. Muller EJ, Williamson L, Kolly C, Suter MM, (2008) Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol 128: 501-516.
42. Aoyama Y, Kitajima Y, (1999) Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 112: 67-71.
43. Aoyama Y, Nagai M, Kitajima Y, (2010) Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. Br J Dermatol 162: 1049-1055.
44. Shu E, Yamamoto Y, Aoyama Y, Kitajima Y, (2007) Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis. Arch Dermatol Res 299: 165-167.
45. Sato M, Aoyama Y, Kitajima Y, (2000) Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 80: 1583-1592.
46. Kawasaki H, Tsunoda K, Hata T, Ishii K, Yamada T, et al. (2006) Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. J Invest Dermatol 126: 2621-2630.
47. Schulze K, Galichet A, Sayar BS, Scothern A, Howald D, et al. (2012) An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol 132: 346-355.
48. Ishii K, Harada R, Matsuo I, Shirakata Y, Hashimoto K, et al. (2005) In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 124: 939-946.
49. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, et al. (2004) IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 122: 1145-1153.
50. Wang W, Amagai M, Ishiko A, (2009) Desmosome splitting is a primary ultrastructural change in the acantholysis of pemphigus. J Dermatol Sci 54: 59-61.
51. Shimizu A, Ishiko A, Ota T, Saito H, Oka H, et al. (2005) In vivo ultrastructural localization of the desmoglein 3 adhesive interface to the desmosome mid-line. J Invest Dermatol 124: 984-989.
52. Oktarina DA, van der Wier G, Diercks GF, Jonkman MF, Pas HH, (2011) IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol 165: 552-562.
53. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D, (2005) Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 115: 3157-3165.
54. LaFlamme SE, Thomas LA, Yamada SS, Yamada KM, (1994) Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly. J Cell Biol 126: 1287-1298.
55. Setzer SV, Calkins CC, Garner J, Summers S, Green KJ, et al. (2004) Comparative analysis of armadillo family proteins in the regulation of a431 epithelial cell junction assembly, adhesion and migration. J Invest Dermatol 123: 426-433.
56. Xiao K, Allison DF, Kottke MD, Summers S, Sorescu GP, et al. (2003) Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells. J Biol Chem 278: 19199-19208.